Metraipolis › archive › dc_a0865281ff38

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy — Europe PMC PMID:42359636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42359636
DOI
10.1080/15384047.2026.2694128
License (as archived)
solo-consultazione
Archived
2026-10-18T19:49:07.258Z
SHA-256 of the archived text
45033333e6afcf887da5156add814fb5d7bf601c11b37be70324735f653ab5e6
Stable URL of this page
https://metraipolis.com/documento/dc_a0865281ff38

How to cite

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy — Europe PMC PMID:42359636 — Europe PMC (en), https://europepmc.org/article/MED/42359636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a0865281ff38 (Metraipolis archive dc_a0865281ff38, sha256 45033333e6afcf887da5156add814fb5d7bf601c11b37be70324735f653ab5e6)
BibTeX
@misc{dca0865281ff38,
  title = {Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy — Europe PMC PMID:42359636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42359636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a0865281ff38; sha256 45033333e6afcf887da5156add814fb5d7bf601c11b37be70324735f653ab5e6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42359636. Agents can read the archived copy with the MCP tool read_document.